In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...
The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...
Key Takeaways Hims & Hers shares gained Monday after the Food and Drug Administration said compounding pharmacies could ...